GAO Report on MA Behavioral Health Prior Authorization

July 9, 2025

Medicare

On May 29, the Government Accountability Office (GAO) released a report evaluating how Medicare Advantage (MA) organizations use prior authorization (PA) and internal coverage criteria to determine beneficiary access to behavioral health services, finding that these tools frequently delay care, burden providers, and contribute to access inequities. GAO found that eight out of the nine MA organizations require PA for various behavioral health services, including inpatient psychiatric care, partial hospitalization programs, and specialized services.

Routine outpatient therapy typically did not require PA, and emergency services were generally exempt but often subject to concurrent review. Seven of the eight organizations reported relying on internal coverage criteria for PA decisions rather than CMS guidelines. While the internal criteria sources generally offered more detailed clinical thresholds than Medicare coverage rules, behavioral health providers told GAO that MA organizations applied these criteria inconsistently, even when using the same sources.

GAO also found that CMS provides limited oversight of these practices, specifically not targeting behavioral health services in its program audits or reviews of PA denials, raising concerns about transparency, accountability, and alignment with federal behavioral health priorities. The report recommends that CMS strengthen oversight and improve access for MA enrollees, including targeting behavioral health services in its program audit. CMS stated that it would take the recommendation under advisement.

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like